Largest Primary Progressive Multiple Sclerosis Drug Trial
Fleishman-Hillard, Kansas CityThe largest drug trial ever for multiple sclerosis will launch March 1 at The University of Texas--Houston Health Science Center. It will investigate whether COPAXONE can slow the progression of primary progressive MS.